Lenabasum Open-Label Extension Data to be Presented at EULAR 2019 Continue to Show a Favorable Safety Profile and Improvement in Efficacy Outcomes in Systemic Sclerosis and Dermatomyositis Phase 2 Studies

World News: . []

Norwood MA June 12 2019 GLOBE NEWSWIRE -- LINK  Pharmaceuticals Holdings Inc NASDAQ CRBP Corbus or the LINK  today announced continued LINK  safety and durable improvement in LINK  outcomes at 21 months LINK  t o 12 mo...

More news and information about Corbus Pharmaceuticals Holdings, Inc.

Published By:

Globe Newswire: 13:05 GMT Wednesday 12th June 2019

Published: .

Search for other references to "lenabasum" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us